6.
Singh S, Srinivasan K, Gowthamarajan K, Singare D, Prakash D, Gaikwad N
. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur J Pharm Biopharm. 2011; 78(3):441-6.
DOI: 10.1016/j.ejpb.2011.03.014.
View
7.
Ghosh I, Schenck D, Bose S, Ruegger C
. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of Vitamin E TPGS and nanocrystal particle size on oral absorption. Eur J Pharm Sci. 2012; 47(4):718-28.
DOI: 10.1016/j.ejps.2012.08.011.
View
8.
Peltonen L, Hirvonen J
. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010; 62(11):1569-79.
DOI: 10.1111/j.2042-7158.2010.01022.x.
View
9.
Merisko-Liversidge E, Liversidge G, Cooper E
. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003; 18(2):113-20.
DOI: 10.1016/s0928-0987(02)00251-8.
View
10.
Sharma P, Denny W, Garg S
. Effect of wet milling process on the solid state of indomethacin and simvastatin. Int J Pharm. 2009; 380(1-2):40-8.
DOI: 10.1016/j.ijpharm.2009.06.029.
View
11.
Tanaka Y, Inkyo M, Yumoto R, Nagai J, Takano M, Nagata S
. Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improve in vitro dissolution and in vivo oral absorption. Drug Dev Ind Pharm. 2011; 38(8):1015-23.
DOI: 10.3109/03639045.2011.637051.
View
12.
Parker N, Rahman M, Bilgili E
. Impact of media material and process parameters on breakage kinetics-energy consumption during wet media milling of drugs. Eur J Pharm Biopharm. 2020; 153:52-67.
DOI: 10.1016/j.ejpb.2020.05.024.
View
13.
Cerdeira A, Mazzotti M, Gander B
. Miconazole nanosuspensions: Influence of formulation variables on particle size reduction and physical stability. Int J Pharm. 2010; 396(1-2):210-8.
DOI: 10.1016/j.ijpharm.2010.06.020.
View
14.
Bilgili E, Guner G
. Mechanistic Modeling of Wet Stirred Media Milling for Production of Drug Nanosuspensions. AAPS PharmSciTech. 2020; 22(1):2.
DOI: 10.1208/s12249-020-01876-w.
View
15.
Guner G, Yilmaz D, Bilgili E
. Kinetic and Microhydrodynamic Modeling of Fenofibrate Nanosuspension Production in a Wet Stirred Media Mill. Pharmaceutics. 2021; 13(7).
PMC: 8309173.
DOI: 10.3390/pharmaceutics13071055.
View
16.
Kumar S, Burgess D
. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. Int J Pharm. 2014; 466(1-2):223-32.
DOI: 10.1016/j.ijpharm.2014.03.021.
View
17.
Verma S, Huey B, Burgess D
. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir. 2009; 25(21):12481-7.
DOI: 10.1021/la9016432.
View
18.
Li M, Alvarez P, Bilgili E
. A microhydrodynamic rationale for selection of bead size in preparation of drug nanosuspensions via wet stirred media milling. Int J Pharm. 2017; 524(1-2):178-192.
DOI: 10.1016/j.ijpharm.2017.04.001.
View
19.
Nakach M, Authelin J, Agut C
. New Approach and Practical Modelling of Bead Milling Process for the Manufacturing of Nanocrystalline Suspensions. J Pharm Sci. 2017; 106(7):1889-1904.
DOI: 10.1016/j.xphs.2017.02.036.
View
20.
Tuomela A, Hirvonen J, Peltonen L
. Stabilizing Agents for Drug Nanocrystals: Effect on Bioavailability. Pharmaceutics. 2016; 8(2).
PMC: 4932479.
DOI: 10.3390/pharmaceutics8020016.
View